课题基金 / 基金详情

Access Paths for Sodium-Channel Blocking Antiarrhythmics

Access Paths for Sodium-Channel Blocking Antiarrhythmics
钠通道阻断抗心律失常药物的进入途径
批准号:
6932373
负责人:
PETER J LEE
金额:
$10.02万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-05 至 2006-04-16

项目摘要

项目成果

PETER J LEE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant): The proposal describes a 5-year plan to study the interaction between antiarrhythmic drugs and cardiac sodium channels with an ultimate goal of obtaining insights for a better pharmacologic intervention for deadly arrhythmia. It also serves as a training program for the development of an academic career for the principal investigator as a physician scientist. The principal investigator has completed cardiology and postdoctoral fellowships under the guidance of Dr. Harry A. Fozzard at the University of Chicago and will proceed to lead an independent program in basic cardiac electrophysiology. Dr. Fozzard, who will continue to mentor the principal investigator's development, is one of the pioneers in modern basic cardiac electorphysiology and has trained numerous fellows and students, who have since become prominent researchers throughout the world. The Advisory Committee of highly regarded basic and clinical scientists will provide both scientific and career guidance. Research program focuses on the paths through which antiarrhythmic drugs bind and unbind the voltage-gated sodium channel to modulate the use-dependent block. The proposal builds on the foundations of prior studies in Dr. Fozzard's and other laboratories and uses the framework developed by the principal investigator recently. The specific aims include; 1) the effects of membrane depolarization, often seen in ischemia, on the drug-channel interaction of lidocaine and related compounds, 2) identification of other drug-paths to better characterize the drug-channel interactions and gain further insights into the structure of sodium channel, 3) examine the drug-paths important for use-dependent activities of other classes of antiarrhythmic drugs, and 4) expand into the preliminary findings suggesting that a long-QT mutation in the sodium channel alters drug-paths and consequently use-dependent properties of certain antiarrythmic drugs. The University of Chicago, an institution of international prominence in medical and basic science provides a rigorous academic environment with extensive resources for fostering a successful academic career.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1097/01.crd.0000131188.41589.c5
发表时间: 2005-03-01
期刊: Cardiology in review
影响因子: 2.1
作者: [Lee, Peter J, Mallik, Rajiv]
通讯作者: Mallik, Rajiv
Flecainide sensitivity of a Na channel long QT mutation shows an open-channel blocking mechanism for use-dependent block.
Na 通道长 QT 突变的氟卡尼敏感性显示了使用依赖性阻断的开放通道阻断机制。
DOI: 10.1152/ajpheart.01317.2005
发表时间: 2006
期刊: American journal of physiology. Heart and circulatory physiology
影响因子: --
作者: [Zhu,Yujie, Kyle,JohnW, Lee,PeterJ]
通讯作者: Lee,PeterJ
The voltage dependence of recovery from use-dependent block by QX-222 separates mechanisms for drug egress in the cardiac sodium channel.
QX-222 从使用依赖性阻断中恢复的电压依赖性分离了心脏钠通道中药物流出的机制。
DOI: 10.1016/j.bcp.2006.01.010
发表时间: 2006
期刊: Biochemical pharmacology
影响因子: 5.8
作者: [Lardin,HarveyA, Lee,PeterJ]
通讯作者: Lee,PeterJ
DEFINING THE ACCESS PATH FOR LOCAL ANESTHETIC DRUGS
  • 批准号:
    6498554
  • 项目类别:
  • 资助金额:
    $2.31万
  • 财政年份:
    2002
  • 负责人:
    PETER J LEE
  • 依托单位:
Access Paths for Sodium-Channel Blocking Antiarrhythmics
Access Paths for Sodium-Channel Blocking Antiarrhythmics
Access Paths for Sodium-Channel Blocking Antiarrhythmics
海外基金